Activity and expression of the vanilloid receptor 1 (TRPV1) is altered by long-term diabetes in epineurial arterioles of the rat sciatic nerve

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 3, 2006, Pages 211-219

  Davidson, Eric P ^a   Coppey, Lawrence J ^a   Yorek, Mark A ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Capsaicin; Diabetes; Neuropeptides; Sensory nerves; Vascular reactivity; Vasoconstriction

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CAPSAZEPINE; ENDOTHELIN; NEUROFILAMENT PROTEIN; NEUROKININ A; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; RESINIFERATOXIN; SEROTONIN; STREPTOZOCIN; SUBSTANCE P; VANILLOID RECEPTOR 1; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC MICROANGIOPATHY; DISEASE DURATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INHIBITION KINETICS; INNERVATION; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SCIATIC NERVE; SENSORY NERVE; STREPTOZOCIN DIABETES; VASCULAR RESISTANCE; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIOLES; CAPSAICIN; DIABETES MELLITUS, EXPERIMENTAL; IMMUNOHISTOCHEMISTRY; MALE; MICROSCOPY, VIDEO; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TRPV CATION CHANNELS; VASOCONSTRICTION;

EID: 33744499201     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.599     Document Type: Article

References (32)

1. Yorek MA, Coppey LJ, Gellett JS, et al. Sensory nerve innervation of epineurial arterioles of the sciatic nerve containing calcitonin gene-related peptide: Effect of streptozotocin-induced diabetes. Exp. Diabetes Res. 2004; 5: 187-193.
2. Nagy I, Santha P, Jancso G, et al. The role of the vanilloid (capsaicin) receptor (TRPV1) in physiology and pathology. Eur. J. Pharmacol 2004; 500: 351-369.
3. Tang H-B, Inoue A, Oshita K, et al. Sensitization of vanilloid receptor 1 induced by bradykinin via the activation of second messenger signaling cascades in rat primary afferent neurons. Eur. J. Pharmacol 2004; 498: 37-43.
4. Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur. J. Pharmacol 2004; 500: 231-241.
5. Hong S, Wiley JW. Early painful diabetic neuropathy is associated with differential changes in the expression and function of vanilloid receptor 1. J. Biol. Chem. 2005; 280: 618-627.
6. Terata K, Coppey LJ, Davidson EP, et al. Acetylcholine-induced arteriolar dilation is reduced in streptozotocin-induced diabetic rats with motor nerve dysfunction. Br. J. Pharmacol. 1999; 128: 837-843.
7. Coppey LJ, Davidson EP, Dunlap JA, et al. Slowing of motor nerve conduction velocity in streptozotocin-induced diabetic rats is preceded by impaired vasodilation in arterioles that overlie the sciatic nerve. Int. J. Exp. Diab. Res. 2000; 1: 131-143.
8. Coppey LJ, Gellett JS, Davidson EP, et al. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001; 50: 1927-1937.
9. Qiu J, Steyger PS, Trune DR, Nuttall AL. Co-existence of tyrosine hydroxylase and calcitonin gene-related peptide in cochlear spiral modiolar artery of guinea pigs. Hear Res. 2001; 155: 152-160.
10. Szallashi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999; 51: 159-211.
11. Sheykhzade M, Dalsgaard GT, Johansen T, Nyborg NCB. The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: Selective attenuation of CGRP-induced relaxations. Br. J. Pharmacol. 2000; 129: 1212-1218.
12. Dux M, Santha P, Jancso G. Capsaicin-sensitive neurogenic sensory vasodilation in the dura mater of the rat. J. Physiol. 2003; 552: 859-867.
13. Akerman S, Kaube H, Goadsby PJ. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve play a minor role in neurogenic dural vasodilation and are involved in capsaicin-induced dural dilation. Br. J. Pharmacol. 2003; 140: 718-724.
14. Sams-Nielson A, Orskov C, Jansen-Oleson I. Pharmacological evidence for CGRP uptake into perivascular capsaicin sensitive nerve terminals. Br. J. Pharmacol. 2001; 132: 1145-1153.
15. Peitl B, Petho G, Porszasz R, et al. Capsaicin-insensitive sensory-efferent meningeal vasodilation evoked by electrical stimulation of trigeminal nerve fibres in the rat. Br. J. Pharmacol. 1999; 127: 457-467.
16. Akerman S, Kaube H, Goadsby PJ. Anandamide acts as a vasodilator of dural blood vessels by activating TRPV1 receptors. Br. J. Pharmacol. 2001; 142: 1354-1360.
17. Zygmunt PM, Petersson J, Andersson DA, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-457.
18. Ahluwalia J, Urban L, Bevan S, Istvan N. Anandamide regulates neuropeptide release from capsaicin-sensitive primary neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro. Eur. J. Neurosci. 2003; 17: 2611-2618.
19. Griffiths CD, Geraghty DP, Eldershaw TPD, Colquhoun EQ. Acute and chronic effects of capsaicin in perfused rat muscle: the role of tachykinins and calcitonin gene-related peptide. J. Pharmacology Exp. Thera. 1998; 287: 697-704.
20. Porszasz R, Porkolab A, Ferencz A, et al. Capsaicin-induced nonneural vasoconstriction in canine mesenteric arteries. Eur. J. Pharmacol 2002; 441: 173-175.
21. Sasamura T, Kuraishi Y. Peripheral and central actions of capsaicin and VR1 receptor. Jpn. J. Pharmacol. 1999; 80: 275-280.
22. Patterson LM, Zheng H, Ward SM, et al. Vanilloid receptor (VR1) expression in vagal afferent neurons innervating the gastrointestinal tract. Cell Tissue Res. 2003; 311: 277-287.
23. Gunthorpe MJ, Benham CD, Randall A, Davis JB. The diversity in the vanilloid (TRPV) receptor family of ion channels. TRENDS Pharmacol. Sci. 2002; 23: 183-191.
24. Gibbs J, Flores CM, Hargreaves KM. Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism. Neuroscience 2004; 125: 703-709.
25. Zukowska Z, Pons J, Lee EW, Li L. Neuropeptide Y: a new mediator linking sympathetic nerves, blood vessels and immune system? Can. J. Physiol. Pharmacol. 2003; 81: 89-94.
26. Zukowska Z, Grant DS, Lee EW. Neuropeptide Y: a novel mechanism for ischemic angiogenesis. Trends Cardiovasc. Med. 2003; 13: 86-92.
27. Lin Q, Zou X, Ren Y, et al. Involvement of peripheral neuropeptide Y in sympathetic modulation of acute cutaneous flare induced by intradermal capsaicin. Neuroscience 2004; 123: 337-347.
28. Beggs J, Johnson PC, Olafsen A, Watkins CJ. Innervation of the vasa nervorum: changes in human diabetics. J. Neuropathol. Exp. Neurol. 1192; 51: 612-629.
29. Lincoln J, Milner P, Appenzeller O, et al. Innervation of normal human sural and optic nerves by noradrenaline- and peptide-containing nerve vasorum and nervorum: effect of diabetes and alcoholism. Brain Res. 1993; 632: 48-56.
30. Teunissen LL, Veldink J, Notermans NC, Bleys RLAW. Quantitative assessment of the innervation of epineurial arteries in the peripheral nerve by immunofluorescence: differences between controls and patients with peripheral arterial disease. Acta Neuropathol 2002; 103: 475-480.
31. Spangeus A, Suhr O, El-Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol. Histopathol 2000; 15: 739-744.
32. Kumar SD, Tay SS. Changes in peptidergic nerves in the atrioventricular valves of streptozotocin-induced diabetic rats: a confocal microscopy study. Anat. Rec. 2002; 258: 277-285.